Abiopharma

🔍 DONDERO JAMES D (Director)

Company: NEXPOINT DIVERSIFIED REAL ESTATE TRUST (NXDT)

Report Date: 2026-03-18

Detailed Transactions and Holdings:

• Acquired 73,125 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,702,698.06 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: As custodian of UTMA account for child 1 | shares_owned_after: 7,098.87 | Footnotes: F2, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: As custodian of UTMA account for child 2 | shares_owned_after: 7,083.04 | Footnotes: F2, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: As custodian of UTMA account for child 3 | shares_owned_after: 7,098.88 | Footnotes: F2, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: As custodian of UTMA account for child 4 | shares_owned_after: 5,263.48 | Footnotes: F2, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: As custodian of UTMA account for child 5 | shares_owned_after: 5,037.92 | Footnotes: F2, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: As custodian of UTMA account for child 6 | shares_owned_after: 7,098.88 | Footnotes: F2, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 2,827,561.05 | Footnotes: F2, F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 821,015.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 2,231,103.00 | Footnotes: F6
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 628,351.00 | Footnotes: F7
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: By employee benefit plan | shares_owned_after: 87,330.65 | Footnotes: F2
• Sold 73,125 shares of Restricted Share Units (Derivative)
  Date: 2026-03-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 146,250.00 | transaction_form_type: 4 | Footnotes: F1, F8, F8

Footnotes:

• F1: Each restricted share unit represents a contingent right to receive one common share of NexPoint Diversified Real Estate Trust (the "Company").
• F2: Includes shares acquired under a dividend reinvestment plan and shares received pursuant to elective stock dividends paid on the Company's common shares.
• F3: The shares are held for one of Mr. Dondero's children, through a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA") for which Mr. Dondero serves as custodian. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
• F4: 41,733 shares are held by Drugcrafters, L.P. ("Drugcrafters"), 92,230.17 shares are held by PCMG Trading Partners XXIII, L.P., 290,517 shares are held by Governance Re Ltd., 14,962.88 shares are held by Highland Capital Management Services, L.P. ("HCM") and 2,388,118 shares are held by NexPoint Real Estate Advisers X, L.P. (the "Adviser"). Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and HCM, and PCMG owns 99% of Drugcrafters. Drugcrafters, PCMG, Governance Re Ltd., HCM and the Adviser are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
• F5: These shares are held by The Dugaboy Investment Trust of which Mr. Dondero is the beneficiary pursuant to an employee purchase plan. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
• F6: 1,559,149 shares are held by Highland Opportunities and Income Fund and 671,954 shares are held by Highland Global Allocation Fund (both of which are managed by NexPoint Asset Management, L.P., which is ultimately controlled by Mr. Dondero). Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
• F7: These shares are held by subsidiaries of The Dugaboy Investment Trust. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
• F8: On March 18, 2024, the reporting person was granted 292,500 restricted share units. The restricted share units vested one-fourth on March 18, 2025 and one-fourth on March 18, 2026, and will vest one-fourth on March 18, 2027 and one-fourth on March 18, 2028. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash.
• REMARKS: President